Cargando…

Clinical Diversity in Patients with Anderson-fabry Disease with the R301Q Mutation

Anderson-Fabry disease (AFD) is a rare X-linked disorder caused by deficient activity of the lysosomal enzyme α-galactosidase A (α-GAL A). We herein report 10 cases of AFD in 5 families (3 men and 7 women) that were found to have a specific common mutation in R301Q [G-to-A transition in exon 6 (codo...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamamoto, Saori, Nagasawa, Tasuku, Sugimura, Koichiro, Kanno, Atsuhiro, Tatebe, Shunsuke, Aoki, Tatsuo, Sato, Haruka, Kozu, Katsuya, Konno, Ryo, Nochioka, Kotaro, Satoh, Kimio, Shimokawa, Hiroaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6421142/
https://www.ncbi.nlm.nih.gov/pubmed/30333391
http://dx.doi.org/10.2169/internalmedicine.0959-18
Descripción
Sumario:Anderson-Fabry disease (AFD) is a rare X-linked disorder caused by deficient activity of the lysosomal enzyme α-galactosidase A (α-GAL A). We herein report 10 cases of AFD in 5 families (3 men and 7 women) that were found to have a specific common mutation in R301Q [G-to-A transition in exon 6 (codon 301) resulting in the replacement of a glutamine with an arginine residue]. We evaluated their clinical characteristics, residual enzymatic activity, and plasma concentrations of globotriaosylsphingosine (Lyso-Gb3). Although all 10 cases had cardiac and renal manifestations in common, their clinical manifestations were markedly divergent despite the same genetic abnormality.